179 related articles for article (PubMed ID: 11085188)
1. Glucocorticoid receptors in patients with congenital adrenal hyperplasia.
Saka N; Güven M; Baş F; Darendeliler F; Bundak R; Günöz H; Sultuybek G
J Pediatr Endocrinol Metab; 2000; 13(8):1101-7. PubMed ID: 11085188
[TBL] [Abstract][Full Text] [Related]
2. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
[TBL] [Abstract][Full Text] [Related]
4. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
5. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
[TBL] [Abstract][Full Text] [Related]
6. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
[TBL] [Abstract][Full Text] [Related]
7. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
Hampl R; Foretová L; Sulcová J; Stárka L
Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
[TBL] [Abstract][Full Text] [Related]
8. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
9. Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.
Dubinski I; Bechtold Dalla-Pozza S; Bidlingmaier M; Reisch N; Schmidt H
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1543-1548. PubMed ID: 34523293
[TBL] [Abstract][Full Text] [Related]
10. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets.
Sarafoglou K; Gonzalez-Bolanos MT; Zimmerman CL; Boonstra T; Yaw Addo O; Brundage R
J Clin Pharmacol; 2015 Apr; 55(4):452-7. PubMed ID: 25385533
[TBL] [Abstract][Full Text] [Related]
13. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
[TBL] [Abstract][Full Text] [Related]
14. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM; London DR
Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
[TBL] [Abstract][Full Text] [Related]
15. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
16. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
Cetinkaya S; Kara C
J Pediatr Endocrinol Metab; 2011; 24(5-6):265-9. PubMed ID: 21823521
[TBL] [Abstract][Full Text] [Related]
17. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS; Ljubicic ML; Main KM; Andersson AM; Petersen JH; Frederiksen H; Duno M; Johannsen TH; Juul A
Horm Res Paediatr; 2020; 93(4):226-238. PubMed ID: 33017824
[TBL] [Abstract][Full Text] [Related]
19. Salt wasting in simple virilizing congenital adrenal hyperplasia.
Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children.
Ghizzoni L; Bernasconi S; Virdis R; Vottero A; Ziveri M; Volta C; Iughetti L; Giovannelli G
Metabolism; 1994 Mar; 43(3):372-7. PubMed ID: 8139487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]